Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2012; 18(15): 1723-1731
Published online Apr 21, 2012. doi: 10.3748/wjg.v18.i15.1723
Published online Apr 21, 2012. doi: 10.3748/wjg.v18.i15.1723
Table 1 Cumulative rate (Cum %) of CD patients with relapsing disease during the first year and in the periods 1-5 and 5-10 years after diagnosis (Solberg et al[30], with permission)
| Relapse during the 1st year | Relapse between 1-5 yr | Relapse between 5-10 yr | |||||
| Variables at diagnosis | Total in each subgroup | cum%(CI) | P value | cum%(CI) | P value | cum%(CI) | P value |
| Age groups | |||||||
| A1 < 40 yr | 148 | 54 (50-58) | 0.7 | 80 (77-83) | 0.6 | 61 (57-65) | 0.03 |
| A2 ≥ 40 yr | 49 | 51 (44-58) | 76 (70-82) | 43 (36-50) | |||
| Gender | |||||||
| Female | 95 | 54 (49-59) | 0.9 | 76 (72-80) | 0.4 | 56 (51-61) | 0.9 |
| Male | 102 | 53 (48-58) | 81 (77-85) | 57 (52-62) | |||
| Location | |||||||
| L1: Terminal ileum | 51 | 54 (47-61) | 0.4 | 78 (72-84) | 0.8 | 57 (50-64) | 0.1 |
| L2: Colon | 94 | 57 (52-64) | 76 (72-80) | 49 (44-54) | |||
| L3: Ileocolon | 48 | 44 (37-51) | 81 (75-87) | 69 (62-76) | |||
| L4: Upper GI | 4 | 75 (53-97) | 100 (-) | 75 (53-97) | |||
| Behavior | |||||||
| B1: Inflammatory | 127 | 56 (52-60) | 0.7 | 79 (75-83) | 0.6 | 54 (50-58) | 0.4 |
| B2: Stricturing | 50 | 49 (42-56) | 74 (68-78) | 64 (57-71) | |||
| B3: Penetrating | 20 | 50 (39-61) | 85 (77-93) | 55 (44-66) | |||
| Systemic steroids | |||||||
| No | 86 | 47 (42-52) | 0.08 | 69 (64-74) | 0.008 | 47 (42-52) | 0.02 |
| Yes | 109 | 59 (54-64) | 85 (82-88) | 63 (58-68) | |||
| Missing | 2 | - | - | - | |||
| Smoking status | |||||||
| Never | 82 | 52 (47-57) | 0.5 | 79 (75-84) | 0.9 | 59 (54-64) | 0.09 |
| Current smoker | 82 | 57 (52-62) | 79 (75-84) | 61 (56-66) | |||
| Ex-smoker | 29 | 45 (36-54) | 76 (68-84) | 38 (29-47) | |||
| Missing | 4 | - | - | - | |||
| Total | 197 | 54 (50-57) | 79 (76-82) | 56 (53-60) | |||
Table 2 Risk factors at diagnosis associated with surgery during follow-up analyzed by Cox regression (Solberg et al[30], with permission)
| Unadjusted | Adjusted | |||||||
| Variables at diagnosis | Number in analysis | Number with surgery (%) | HR | 95% CI | P value | HR | 95% CI | P value |
| Age | ||||||||
| A1: < 40 yr | 165 | 69 (42) | 1 | [Ref] | 0.03 | 1 | [Ref] | 0.03 |
| A2: ≥ 40 yr | 72 | 16 (22) | 0.5 | 0.3-0.9 | 0.5 | 0.3-0.9 | ||
| Gender | ||||||||
| Female | 118 | 40 (34) | 1 | [Ref] | 0.9 | Not included | ||
| Male | 119 | 45 (38) | 1 | 0.7-1.6 | ||||
| Location | ||||||||
| L1: Terminal ileum | 64 | 38 (59) | 1 | [Ref] | < 0.001 | 1 | [Ref] | |
| L2: Isolated colonic | 115 | 26 (23) | 0.2 | 0.1-0.4 | 0.3 | 0.2-0.6 | 0.001 | |
| L3: Ileocolon | 54 | 17 (32) | 0.3 | 0.2-0.6 | 0.3 | 0.2-0.5 | < 0.001 | |
| L4: Upper GI1 | 4 | 4 (100) | 1.4 | 0.5-3.8 | 1.6 | 0.5-4.4 | 0.4 | |
| Behavior | ||||||||
| B1: Inflammatory | 147 | 32 (22) | 1 | [Ref] | < 0.001 | 1 | [Ref] | |
| B2: Stricturing | 64 | 36 (56) | 3.5 | 2.1-5.6 | 2.3 | 1.3-4.1 | 0.004 | |
| B3: Penetrating | 26 | 17 (65) | 4.9 | 2.7-8.8 | 5.4 | 3.0-9.9 | < 0.001 | |
| Smoking status2 | ||||||||
| Never | 103 | 38 (37) | 1 | [Ref] | 0.2 | Not included | ||
| Current < 10 cigarettes/d | 57 | 18 (32) | 0.8 | 0.4-1.4 | ||||
| Current > 10 cigarettes/d | 36 | 18 (50) | 1.9 | 0.8-2.6 | ||||
| Ex-smoker | 35 | 11 (31) | 0.8 | 0.4-1.6 | ||||
| Systemic steroids3 | ||||||||
| No | 106 | 36 (34) | 1 | [Ref] | 0.8 | Not included | ||
| Yes | 129 | 48 (37) | 1.1 | 0.7-1.6 | ||||
- Citation: Hovde &, Moum BA. Epidemiology and clinical course of Crohn's disease: Results from observational studies. World J Gastroenterol 2012; 18(15): 1723-1731
- URL: https://www.wjgnet.com/1007-9327/full/v18/i15/1723.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i15.1723
